Fosinopril sodium 40 MG Oral Tablet — RxCUI 857187
RxNorm drug concept · Semantic clinical drug
RxCUI 857187
Semantic clinical drug · SCD
● Current RxNorm concept 18 FDA products
36 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI857187
Official nameFosinopril sodium 40 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asFNP Sodium 40 MG Oral Tablet
FDA products mapped18
Package NDCs mapped36
Reported Medicaid activity (SDUD)4,328 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Fosinopril: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Fosinopril is used to treat two main conditions: high blood pressure and heart failure. For high blood pressure, it can be used on its own or paired with a water pill (diuretic) if...
- Yes, a dry, persistent cough is a well-known side effect of this whole class of medications, including fosinopril. It affects some patients and not others — there's no way to predi...
- I keep hearing that ACE inhibitors cause a cough. Is that true with fosinopril?
- The most urgent thing is sudden swelling of your face, lips, tongue, or throat — that's called angioedema, and it can block your airway. If that happens, call 911 immediately; don'...
🕸️ Concept Web — How Fosinopril sodium 40 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Fosinopril sodium 40 MG Oral Tablet
RxCUI 857187 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Fosinopril
50166IN -
Fosinopril sodium
227278PIN
-
Fosinopril
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Fosinopril Oral Tablet
372274SCDF -
Fosinopril sodium Oral Tablet
2646057SCDFP -
Fosinopril Oral Product
1162676SCDG -
Fosinopril Pill
1162677SCDG -
Fosinopril sodium Oral Product
2662241SCDGP -
Fosinopril sodium Pill
2663522SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Fosinopril Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Fosinopril sodium 40 MG
857186SCDC
-
Fosinopril sodium 40 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Fosinopril sodium 40 MG
SCDC · 857186 -
Fosinopril Oral Tablet
SCDF · 372274 -
Fosinopril sodium Oral Tablet
SCDFP · 2646057 -
Fosinopril Oral Product
SCDG · 1162676 -
Fosinopril Pill
SCDG · 1162677 -
Fosinopril sodium Oral Product
SCDGP · 2662241 -
Fosinopril sodium Pill
SCDGP · 2663522
📦 FDA Products & Package NDCs
18 products · 36 package NDCs
36 package NDCs map to RxCUI 857187 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 43547-0386-09 | 90 TABLET in 1 BOTTLE (43547-386-09) | Fosinopril sodium | Solco Healthcare LLC | 2017-10-01 |
| 43547-0386-11 | 1000 TABLET in 1 BOTTLE (43547-386-11) | Fosinopril sodium | Solco Healthcare LLC | 2017-10-01 |
| 43547-0387-09 | 90 TABLET in 1 BOTTLE (43547-387-09) | Fosinopril sodium | Solco Healthcare LLC | 2017-10-01 |
| 43547-0387-11 | 1000 TABLET in 1 BOTTLE (43547-387-11) | Fosinopril sodium | Solco Healthcare LLC | 2017-10-01 |
| 43547-0388-09 | 90 TABLET in 1 BOTTLE (43547-388-09) | Fosinopril sodium | Solco Healthcare LLC | 2017-10-01 |
| 43547-0388-11 | 1000 TABLET in 1 BOTTLE (43547-388-11) | Fosinopril sodium | Solco Healthcare LLC | 2017-10-01 |
| 50090-2977-00 | 30 TABLET in 1 BOTTLE (50090-2977-0) | Fosinopril Sodium | A-S Medication Solutions | 2017-04-18 |
| 50090-4743-00 | 30 TABLET in 1 BOTTLE (50090-4743-0) | Fosinopril sodium | A-S Medication Solutions | 2019-11-21 |
| 50090-4743-01 | 90 TABLET in 1 BOTTLE (50090-4743-1) | Fosinopril sodium | A-S Medication Solutions | 2019-11-21 |
| 62135-0041-90 | 90 TABLET in 1 BOTTLE (62135-041-90) | Fosinopril Sodium | Chartwell RX, LLC | 2023-06-01 |
| 62135-0042-90 | 90 TABLET in 1 BOTTLE (62135-042-90) | Fosinopril Sodium | Chartwell RX, LLC | 2023-06-01 |
| 62135-0043-90 | 90 TABLET in 1 BOTTLE (62135-043-90) | Fosinopril Sodium | Chartwell RX, LLC | 2023-06-01 |
| 65862-0471-30 | 30 TABLET in 1 BOTTLE (65862-471-30) | Fosinopril Sodium | Aurobindo Pharma Limited | 2011-03-30 |
| 65862-0471-90 | 90 TABLET in 1 BOTTLE (65862-471-90) | Fosinopril Sodium | Aurobindo Pharma Limited | 2011-03-30 |
| 65862-0471-99 | 1000 TABLET in 1 BOTTLE (65862-471-99) | Fosinopril Sodium | Aurobindo Pharma Limited | 2011-03-30 |
| 65862-0472-30 | 30 TABLET in 1 BOTTLE (65862-472-30) | Fosinopril Sodium | Aurobindo Pharma Limited | 2011-03-30 |
| 65862-0472-90 | 90 TABLET in 1 BOTTLE (65862-472-90) | Fosinopril Sodium | Aurobindo Pharma Limited | 2011-03-30 |
| 65862-0472-99 | 1000 TABLET in 1 BOTTLE (65862-472-99) | Fosinopril Sodium | Aurobindo Pharma Limited | 2011-03-30 |
| 65862-0473-30 | 30 TABLET in 1 BOTTLE (65862-473-30) | Fosinopril Sodium | Aurobindo Pharma Limited | 2011-03-30 |
| 65862-0473-90 | 90 TABLET in 1 BOTTLE (65862-473-90) | Fosinopril Sodium | Aurobindo Pharma Limited | 2011-03-30 |
| 65862-0473-99 | 1000 TABLET in 1 BOTTLE (65862-473-99) | Fosinopril Sodium | Aurobindo Pharma Limited | 2011-03-30 |
| 69097-0856-05 | 90 TABLET in 1 BOTTLE (69097-856-05) | Fosinopril Sodium | Cipla USA Inc. | 2016-06-16 |
| 69097-0856-15 | 1000 TABLET in 1 BOTTLE (69097-856-15) | Fosinopril Sodium | Cipla USA Inc. | 2016-06-16 |
| 69097-0857-05 | 90 TABLET in 1 BOTTLE (69097-857-05) | Fosinopril Sodium | Cipla USA Inc. | 2016-06-16 |
| 69097-0857-15 | 1000 TABLET in 1 BOTTLE (69097-857-15) | Fosinopril Sodium | Cipla USA Inc. | 2016-06-16 |
| 69097-0858-05 | 90 TABLET in 1 BOTTLE (69097-858-05) | Fosinopril Sodium | Cipla USA Inc. | 2016-06-16 |
| 69097-0858-15 | 1000 TABLET in 1 BOTTLE (69097-858-15) | Fosinopril Sodium | Cipla USA Inc. | 2016-06-16 |
| 71335-9703-01 | 30 TABLET in 1 BOTTLE (71335-9703-1) | Fosinopril sodium | Bryant Ranch Prepack | 2023-05-11 |
| 71335-9703-02 | 90 TABLET in 1 BOTTLE (71335-9703-2) | Fosinopril sodium | Bryant Ranch Prepack | 2023-05-11 |
| 71335-9703-03 | 28 TABLET in 1 BOTTLE (71335-9703-3) | Fosinopril sodium | Bryant Ranch Prepack | 2023-05-11 |
| 76282-0200-10 | 1000 TABLET in 1 BOTTLE (76282-200-10) | Fosinopril sodium | Exelan Pharmaceuticals, Inc. | 2005-06-21 |
| 76282-0200-90 | 90 TABLET in 1 BOTTLE (76282-200-90) | Fosinopril sodium | Exelan Pharmaceuticals, Inc. | 2005-06-21 |
| 76282-0201-10 | 1000 TABLET in 1 BOTTLE (76282-201-10) | Fosinopril sodium | Exelan Pharmaceuticals, Inc. | 2005-06-21 |
| 76282-0201-90 | 90 TABLET in 1 BOTTLE (76282-201-90) | Fosinopril sodium | Exelan Pharmaceuticals, Inc. | 2005-06-21 |
| 76282-0202-10 | 1000 TABLET in 1 BOTTLE (76282-202-10) | Fosinopril sodium | Exelan Pharmaceuticals, Inc. | 2005-06-21 |
| 76282-0202-90 | 90 TABLET in 1 BOTTLE (76282-202-90) | Fosinopril sodium | Exelan Pharmaceuticals, Inc. | 2005-06-21 |
Observed labelers:
Aurobindo Pharma Limited (9) ·
Cipla USA Inc. (6) ·
Exelan Pharmaceuticals, Inc. (6) ·
Solco Healthcare LLC (6) ·
A-S Medication Solutions (3) ·
Bryant Ranch Prepack (3)
· +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.